Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891710083> ?p ?o ?g. }
- W2891710083 endingPage "528" @default.
- W2891710083 startingPage "512" @default.
- W2891710083 abstract "A series of new coumarin-dithiocarbamate hybrids were designed and synthesized as multitarget agents for the treatment of Alzheimer's disease. Most of them showed potent and clearly selective inhibition towards AChE and MAO-B. Among these compounds, compound 8f demonstrated the most potent inhibition to AChE with IC50 values of 0.0068 μM and 0.0089 μM for eeAChE and hAChE, respectively. Compound 8g was identified as the most potent inhibitor to hMAO-B, and it is also a good and balanced inhibitor to both hAChE and hMAO-B (0.114 µM for hAChE; 0.101 µM for hMAO-B). Kinetic and molecular modeling studies revealed that 8g was a dual binding site inhibitor for AChE and a competitive inhibitor for MAO-B. Further studies indicated that 8g could penetrate the BBB and exhibit no toxicity on SH-SY5Y neuroblastoma cells. More importantly, 8g did not display any acute toxicity in mice at doses up to 2500 mg/kg and could reverse the cognitive dysfunction of scopolamine-induced AD mice. Overall, these results highlighted 8g as a potential multitarget agent for AD treatment and offered a starting point for design of new multitarget AChE/MAO-B inhibitors based on dithiocarbamate scaffold." @default.
- W2891710083 created "2018-09-27" @default.
- W2891710083 creator A5001357108 @default.
- W2891710083 creator A5018708800 @default.
- W2891710083 creator A5019174025 @default.
- W2891710083 creator A5035282947 @default.
- W2891710083 creator A5047535787 @default.
- W2891710083 creator A5053139417 @default.
- W2891710083 creator A5064077135 @default.
- W2891710083 creator A5072480947 @default.
- W2891710083 creator A5077655388 @default.
- W2891710083 creator A5077732304 @default.
- W2891710083 creator A5087054079 @default.
- W2891710083 date "2018-12-01" @default.
- W2891710083 modified "2023-10-09" @default.
- W2891710083 title "Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation" @default.
- W2891710083 cites W1561647671 @default.
- W2891710083 cites W1940331911 @default.
- W2891710083 cites W1965718249 @default.
- W2891710083 cites W1971048984 @default.
- W2891710083 cites W1974015220 @default.
- W2891710083 cites W1975286611 @default.
- W2891710083 cites W1975792122 @default.
- W2891710083 cites W1981775239 @default.
- W2891710083 cites W1986092078 @default.
- W2891710083 cites W1986685211 @default.
- W2891710083 cites W2008008517 @default.
- W2891710083 cites W2025022665 @default.
- W2891710083 cites W2026976753 @default.
- W2891710083 cites W2029365157 @default.
- W2891710083 cites W2031922358 @default.
- W2891710083 cites W2032760290 @default.
- W2891710083 cites W2035271554 @default.
- W2891710083 cites W2035289339 @default.
- W2891710083 cites W2036755018 @default.
- W2891710083 cites W2039402692 @default.
- W2891710083 cites W2051124828 @default.
- W2891710083 cites W2051855845 @default.
- W2891710083 cites W2057698260 @default.
- W2891710083 cites W2058840940 @default.
- W2891710083 cites W2062281559 @default.
- W2891710083 cites W2079861976 @default.
- W2891710083 cites W2084972185 @default.
- W2891710083 cites W2085307991 @default.
- W2891710083 cites W2085958374 @default.
- W2891710083 cites W2089013306 @default.
- W2891710083 cites W2095451361 @default.
- W2891710083 cites W2120586432 @default.
- W2891710083 cites W2140642212 @default.
- W2891710083 cites W2144135498 @default.
- W2891710083 cites W2239626215 @default.
- W2891710083 cites W2287707785 @default.
- W2891710083 cites W2316018428 @default.
- W2891710083 cites W2346274463 @default.
- W2891710083 cites W2411084687 @default.
- W2891710083 cites W2414131286 @default.
- W2891710083 cites W2473263270 @default.
- W2891710083 cites W2507283455 @default.
- W2891710083 cites W2520314110 @default.
- W2891710083 cites W2590350493 @default.
- W2891710083 cites W2739708140 @default.
- W2891710083 cites W2769095960 @default.
- W2891710083 cites W2782078111 @default.
- W2891710083 cites W2793377695 @default.
- W2891710083 cites W2795744705 @default.
- W2891710083 cites W883464414 @default.
- W2891710083 doi "https://doi.org/10.1016/j.bioorg.2018.09.010" @default.
- W2891710083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30245233" @default.
- W2891710083 hasPublicationYear "2018" @default.
- W2891710083 type Work @default.
- W2891710083 sameAs 2891710083 @default.
- W2891710083 citedByCount "66" @default.
- W2891710083 countsByYear W28917100832019 @default.
- W2891710083 countsByYear W28917100832020 @default.
- W2891710083 countsByYear W28917100832021 @default.
- W2891710083 countsByYear W28917100832022 @default.
- W2891710083 countsByYear W28917100832023 @default.
- W2891710083 crossrefType "journal-article" @default.
- W2891710083 hasAuthorship W2891710083A5001357108 @default.
- W2891710083 hasAuthorship W2891710083A5018708800 @default.
- W2891710083 hasAuthorship W2891710083A5019174025 @default.
- W2891710083 hasAuthorship W2891710083A5035282947 @default.
- W2891710083 hasAuthorship W2891710083A5047535787 @default.
- W2891710083 hasAuthorship W2891710083A5053139417 @default.
- W2891710083 hasAuthorship W2891710083A5064077135 @default.
- W2891710083 hasAuthorship W2891710083A5072480947 @default.
- W2891710083 hasAuthorship W2891710083A5077655388 @default.
- W2891710083 hasAuthorship W2891710083A5077732304 @default.
- W2891710083 hasAuthorship W2891710083A5087054079 @default.
- W2891710083 hasConcept C178790620 @default.
- W2891710083 hasConcept C181199279 @default.
- W2891710083 hasConcept C185592680 @default.
- W2891710083 hasConcept C202751555 @default.
- W2891710083 hasConcept C2777545050 @default.
- W2891710083 hasConcept C2777752497 @default.
- W2891710083 hasConcept C2778816929 @default.
- W2891710083 hasConcept C2779059548 @default.
- W2891710083 hasConcept C2779491297 @default.